The application of layered double hydroxide clay (LDH)-poly(lactide-co- glycolic acid) (PLGA) film composites for the controlled release of antibiotics

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 7, 2012, Pages 1705-1713

  Chakraborti, Michelle ^a   Jackson, John K ^a   Plackett, David ^b   Gilchrist, Samuel E ^a   Burt, Helen M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

5-FLUOROURACIL; ABSORBANCES; ANTI-MICROBIAL ACTIVITY; ANTISENSE OLIGONUCLEOTIDES; BACTERIAL INFECTIONS; CLAY PARTICLES; CONTROLLED RELEASE; DOXORUBICIN; DRUG RELEASE; EPIDERMIDIS; FILM COMPOSITES; GLYCOLIC ACIDS; HPLC ANALYSIS; LAYERED DOUBLE HYDROXIDES; NANOPARTICULATES; PHOSPHATE-BUFFERED SALINES; POLY LACTIC-CO-GLYCOLIC ACID; TIME POINTS; TIME-PERIODS; VANCOMYCIN;

BONE CEMENT; CENTRIFUGATION; DISPERSIONS; POLYMERIC FILMS; SODIUM;

ANTIBIOTICS;

ANTIBIOTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CARBONIC ACID; DOXORUBICIN; FLUOROURACIL; FUSIDATE SODIUM; HYDROXIDE; NANOCOMPOSITE; NANOPARTICLE; PHOSPHATE BUFFERED SALINE; POLYGLACTIN; TETRACYCLINE; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; CENTRIFUGATION; CLAY; COMPOSITE MATERIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DISPERSION; DRUG BINDING; FILM; FRACTIONATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INCUBATION TEMPERATURE; NONHUMAN; PH; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; SYNTHESIS;

ALUMINUM SILICATES; ANTI-BACTERIAL AGENTS; BIOCOMPATIBLE MATERIALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; LACTIC ACID; POLYGLYCOLIC ACID; SPECTROPHOTOMETRY, ULTRAVIOLET;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84863324348     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4638-y     Document Type: Article

References (24)

1. Li F, Duan X. Layered double hydroxides. Structure and Bonding. Vol.119. In: Duan, Xue, Evans, David G (editors) Applications of layered double hydroxides. Berlin: Springer; 2006. XII.
2. Tarnawski A, Pai R, Itani R, Wyle FA. The antacid Talcid adsorbs and neutralizes all proteins secreted by H. pylori including VacA cytotoxin: a new mechanism for its ulcer-healing action? Digestion. 1999;60(5):449-55. (Pubitemid 29401773)
3. Aguzzi C, Cerezo P, Viseras C, Caramella C. Use of clays as drug delivery systems: possibilities and limitations. Appl Clay Sci. 2007;36(1-3):22-36. doi:10.1016/j.clay.2006.06.015. (Pubitemid 46404593)
4. Mohanambe L, Vasudevan S. Anionic clays containing antiinflammatory drug molecules: comparison of molecular dynamics simulation and measurements. J Phys Chem B. 2005;109(32): 15651-8. doi:10.1021/jp050480m. (Pubitemid 41260815)
5. Li B, He J, Evans DG, Duan X. Inorganic layered double hydroxides as a drug delivery system - intercalation and in vitro release of fenbufen. Appl Clay Sci. 2004;27(3-4):199-207. doi: 10.1016/j.clay.2004.07.002. (Pubitemid 39483540)
6. Khan AI, O'Hare D. Intercalation chemistry of layered double hydroxides: recent developments and applications. J Mater Chem. 2002;12(11):3191-8. doi:10.1039/b204076j.
7. Ambrogi V, Fardella G, Grandolini G, Perioli L. Intercalation compounds of hydrotalcite - like anionic clays with antiinflammatory agents-I. Intercalation and in vitro release of ibuprofen. Int J Pharm. 2001;220(1-2):23-32. (Pubitemid 32476838)
8. Gordijo CuR, Barbosa CsAs, Da Costa Ferreira AM, Constantino VRL, Oliveira Silva Dd. Immobilization of ibuprofen and copperibuprofen drugs on layered double hydroxides. J Pharm Sci. 2005;94(5):1135-48. doi:10.1002/jps. 20336. (Pubitemid 40789962)
9. Kong X, Jin L, Wei M, Duan X. Antioxidant drugs intercalated into layered double hydroxide: structure and in vitro release. Appl Clay Sci. 2010;49(3):324-9. doi:10.1016/j.clay.2010.06.017.
10. Viseras C, Cerezo P, Sanchez R, Salcedo I, Aguzzi C. Current challenges in clay minerals for drug delivery. Appl Clay Sci. 2010;48(3):291-5. doi:10.1016/j.clay.2010.01.007.
11. Trikeriotis M, Ghanotakis DF. Intercalation of hydrophilic and hydrophobic antibiotics in layered double hydroxides. Int J Pharm. 2007;332(1-2):176-84. doi:10.1016/j.ijpharm.2006.09.031. (Pubitemid 46237703)
12. Ryu S-J, Jung H, Oh J-M, Lee J-K, Choy J-H. Layered double hydroxide as novel antibacterial drug delivery system. J Phys Chem Solids. 2010;71(4):685-8. doi:10.1016/j.jpcs.2009.12.066.
13. Tammaro L, Costantino U, Bolognese A, Sammartino G, Marenzi G, Calignano A, et al. Nanohybrids for controlled antibiotic release in topical applications. Int J Antimicrob Agents. 2007;29(4):417-23. doi:10.1016/j.ijantimicag.2006.11. 019. (Pubitemid 46349595)
14. Knetsch MLW, Koole LH. New strategies in the development of antimicrobial coatings: the example of increasing usage of silver and silver nanoparticles. Polymers. 2011;3(1):340-66. doi: 10.3390/polym3010340.
15. Ramritu P, Halton K, Collignon P, Cook D, Fraenkel D, Battistutta D, et al. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. Am J Infect Control. 2008;36(2):104-17. doi:10.1016/j.ajic.2007.02.012. (Pubitemid 351296068)
16. Wu P, Grainger DW. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials. 2006;27(11): 2450-67. doi:10.1016/j. biomaterials.2005.11.031. (Pubitemid 41821824)
17. Jackson J, Leung F, Duncan C, Mugabe C, Burt H. The use of bone cement for the localized, controlled release of the antibiotics vancomycin, linezolid, or fusidic acid: effect of additives on drug release rates and mechanical strength. Drug Deliv Transl Res. 2011;1(2):121-31. doi:10.1007/s13346-011-0015- 5.
18. Andollina A, Bertoni G, Zolezzi C, Trentani F, Trentani P, Maria Borrelli A, et al. Vancomycin and meropenem in acrylic cement: elution kinetics of in vitro bactericidal action. Chir Organi Mov. 2008;91(3):153-8. doi:10.1007/s12306-007-0025-0.
19. Chakraborti M, Jackson JK, Plackett D, Brunette DM, Burt HM. Drug intercalation in layered double hydroxide clay: application in the development of a nanocomposite film for guided tissue regeneration. Int J Pharm. 2011;416(1):305-13. doi:10.1016/j.ijpharm.2011.06.016.
20. Long KA, Jackson JK, Yang C, Chehroudi B, Brunette DM, Burt HM. Controlled release of alendronate from polymeric films. J Biomater Sci Polym Ed. 2009;20(5-6):653-72. doi: 10.1163/156856209X426457.
21. Woodford N, Wareham DW. Tackling antibiotic resistance: a dose of common antisense? J Antimicrob Chemother. 2008;63(2): 225-9. doi:10.1093/jac/dkn467.
22. Chopra I. Prospects for antisense agents in the therapy of bacterial infections. Expert Opin Investig Drugs. 1999;8(8):1203-8. doi:10.1517/13543784. 8.8.1203. (Pubitemid 29410577)
23. Springate CM, Jackson JK, Gleave ME, Burt HM. Clusterin antisense complexed with chitosan for controlled intratumoral delivery. Int J Pharm. 2008;350(1-2):53-64. doi:10.1016/j.ijpharm. 2007.08.018.
24. Ambrogi V, Fardella G, Grandolini G, Perioli L, Tiralti MC. Intercalation compounds of hydrotalcite - like anionic clays with anti-inflammatory agents, II: uptake of diclofenac for a controlled release formulation. AAPS Pharm Sci Tech. 2002;3(3):E26. doi: 10.1208/pt030326.